Investor
Relations

Corporate Overview

Zoar Limited is an international pharmaceutical company engaged in the development of a diversified healthcare platform encompassing pharmaceutical manufacturing, active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO), pharmaceutical trading, and research-driven healthcare solutions.

Established with a long-term growth strategy, the Company is focused on building a sustainable global business through operational excellence, strategic partnerships, and disciplined capital allocation. With its corporate headquarters in the Cayman Islands and operational activities managed through Hong Kong, Zoar Limited continues to expand its presence across Asia, Europe, and the Middle East.

The Company's business model is designed to support every stage of the pharmaceutical value chain—from sourcing and manufacturing to commercialization and global distribution. By combining technical expertise with international market experience, Zoar Limited seeks to deliver high-quality products and reliable supply solutions that meet the evolving needs of customers and healthcare partners.

The Company is committed to maintaining high standards of corporate governance, regulatory compliance, quality management, and ethical business conduct. These principles underpin our operations and support our objective of creating sustainable value for shareholders while delivering long-term benefits to customers, employees, business partners, and the communities in which we operate.

Why Invest

35+

Countries

300+

Million Annual Doses

35+

Products

100+

Distributors

Latest News